SELL Cyient Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)23 Jul 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·21 Oct · yesterday
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·26 Aug · 2mo ago
Cyient Q2 Results: Profit rises 22% to ₹133 crore, revenue up 8%
NewsCnbc-Tv18·22 Oct · today
Cyient Q2 Results: Net Profit Rises 16%, EBIT Margin Expands To 10% QoQ
NewsNdtv-Profit·22 Oct · today
Cyient Limited reported financial results for the quarter ended September 30, 2026, and declared an interim dividend of Rs. 12 per equity share. The company also announced the acquisition of the remai
NSE · Outcome of Board Meeting·22 Oct · today
Cyient shareholders approve Murali Yadama as independent director
NewsGoogle News·14 Oct · 1w ago
Cyient completes ₹720 crore buyback, TAO deal to close in August
NewsGoogle News·30 Sept · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cyient
- BUY — Rakesh Bansal15 Oct 2026 · ~2 weeks · target ₹1,362 · Active
- BUY — Siddharth Rai Mangala14 Oct 2026 · ~2 weeks · target ₹1,350 · SL hit
- BUY — Raja Venkatraman6 Oct 2026 · ~3 months · target ₹1,265 · SL hit
- BUY — Rakesh Bansal5 Oct 2026 · Same day · target ₹1,170 · Target hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities5 Oct 2026 · ~2 weeks · target ₹1,195 · Target hit
More from Motilal Oswal
- BUY Emcure Pharmaceuticals21 Oct 2026 · ~1 year · target ₹2,330 · Active
- BUY Aditya Birla Sun Life AMC21 Oct 2026 · ~1 year · target ₹1,160 · Active
- BUY Mahindra & Mahindra Financial Services21 Oct 2026 · ~1 year · target ₹375 · Active
- BUY Hindalco Industries21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY Eternal21 Oct 2026 · ~1 year · target ₹420 · Active

